I
N 1958, E. C. Heyde 1 reported an association between arteriovenous malformations (AVMs) of the gastrointestinal (GI) tract and aortic stenosis (AS). Subsequent studies in support of Heyde's discovery used indirect clinical criteria, such as idiopathic GI bleeding or heart murmur consistent with AS, to determine the presence of AVMs or AS. [2] [3] [4] [5] Other authors, however, have questioned whether the Heyde syndrome is a real entity. [6] [7] [8] No previous study has shown an association between AS proven by echocardiography and AVMs visualized by GI endoscopy or angiography. The purpose of our study was to determine if there is an association between AS and AVMs of the GI tract using objective diagnostic criteria.
METHODS
Our database included patients who underwent esophagogastroduodenoscopy, pushenteroscopy, colonoscopy, or a mesenteric angiogram between the years 1990 and 2000, and we selected the 177 patients diagnosed with GI AVMs (or any of the synonyms: telangiectasia, angiodysplasia, or vascular malformation). Of these 177 patients, 143 (80.7%) were diagnosed by endoscopy and 34 (19.2%) by angiogram, and 73 (41.2%) also had an echocardiogram at our institution during the same period. The results of the echocardiogram were recorded, with specific attention to the presence and characterization of aortic and mitral stenoses. Mitral stenosis (MS) was selected as a comparative valve lesion, with the assumption that it is equally likely as AS to prompt echocardiographic evaluation. fit the categories of mild stenosis. Therefore, patients with aortic or mitral prosthetic valves were excluded to prevent this group from contributing to stenosis prevalence (Figure 1 ). In the AVM group, 10 patients with valve replacements were excluded for this reason (7 aortic valves for AS, 1 aortic valve for insufficiency, and 2 mitral valves for stenosis).
Since the frequency of AS is not the same among individuals with MS and in the general population, we determined the frequency of these 2 lesions in our total echocardiogram population to compare stenosis frequency in the general population and the AVM group. We evaluated the records of all patients who underwent echocardiograms at this institution for any indication between 1990 and 2000. The same database and search methods were used for the general and the AVM population review. Over 10 years, 102 525 patients had an echocardiogram for any indication. Of these, 10 513 patients were excluded because of the presence of an aortic or mitral prosthesis. The valvular stenoses in the remaining patients were categorized with the same mean gradient criteria as those used for the AVM group, and the demographic characteristics were studied.
The prevalences of AS and MS in the AVM group vs the general echocardiogram population were compared using the Pearson 2 test in a 2ϫ2 contingency table. The significance level was set at ␣=.01. The variation in stenosis severity in each group was compared in a similar manner. Baseline demographic characteristics between groups were compared using the t test with unequal variance and a significance level set at ␣=.01.
RESULTS
Of the 63 patients with AVMs who had echocardiographic evaluations, 20 (31.7%) had AS of any severity, with an average mean aortic gradient of 32.2 mm Hg. In contrast, only 1 patient in this group of 63 patients had MS (1.6%), with a mean gradient of 6 mm Hg (mild stenosis) (Figure 2A ). Interestingly, this patient had concomitant AS. When those with mild stenosis were excluded, the prevalence of significant (moderate or severe) stenosis in patients with AVMs was 15.9% (10/63) for AS, compared with 0% (0/63) for MS ( Figure 2B ). Of the general comparison group of 92 012 patients without a valve prosthesis who were examined using echocardiograms, 12 870 had AS of any severity (14.0%), and 5557 had MS of any severity (6.0%). Excluding patients with mild stenosis, the prevalence of significant (moderate or severe) stenosis in the general comparison population was 6.0% (5548/92 012) for AS, and 1.9% (1769/92 012) for significant MS (Figure 2) . These data reflect a significant 2.3-fold increase in prevalence of AS of any severity in the AVM population compared with the general population (31.7% vs 14.0%; PϽ.001). Similarly, there was a 2.6-fold increase in significant AS in the AVM population (15.9% vs 6.0%; P =.001), and a 4.1-fold increase in severe AS (14.3% vs 3.5%; PϽ.001) ( Table 1) . In contrast, the prevalence of MS was not statistically different between the AVM and general populations, among patients with any MS (1.6% vs 6.0%; P=.14), or those with significant MS (0% vs 1.9%; P=.27) (Figure 2 ).
There were no significant differences in the demographic distribution of the AVM and general population groups studied with regard to average age or sex ( Table 2) . However, there was a higher number of black patients in the AVM group (PϽ.001).
COMMENT

CLINICAL IMPLICATIONS OF HEYDE SYNDROME
The association between AS and AVMs shown in this study will affect decisions for patients presenting with aortic valve or intestinal manifestations. Patients who present with GI bleeding, particularly those in whom no cause is found during the initial endoscopic investigations, should have a thorough examination to detect a possible a systolic murmur. Physicians should have a low threshold for performing an echocardiogram to exclude AS. In extensive GI bleeding due to AVMs, bowel resection is sometimes needed. In Heyde syndrome, even if the GI bleeding has been controlled with a bowel resection, the patient is left unprotected from a potentially lethal valve disease when AS is not detected. Numerous authors have reported cessation of GI bleeding after aortic valve replacement (AVR), 9-11 and King et al 12 showed that GI surgery was successful in preventing recurrent GI bleeding in only 5% of the patients with AVMs, compared with a 93% effectiveness with AVR.
All patients who present with AS should at least be screened for occult GI blood loss. If ill-defined bleeding is found, the possibility of Heyde syndrome should be investigated. In particular, mechanical AVR in a patient with Heyde syndrome should be approached cautiously, because anticoagulation could exacerbate the GI bleeding if it persists after surgery. 13 The threshold for performing an AVR on patients with Heyde syndrome should be affected by the anticipated effects on both the GI bleeding and the valvular hemodynamics. Some patients with Heyde syndrome may develop anemia owing to a slow GI bleeding, which causes them to become symptomatic earlier in the course of AS. If GI lesions can be treated endoscopically, this may reduce perioperative bleeding and stabilize hemodynamics at the time of aortic valve surgery.
To date, the very existence of Heyde syndrome has been controversial. In addition to the original report by Heyde, Williams 2 found that 25% of patients with unexplained GI bleeding had AS and Cody et al 3 found that patients with AS were 100 times more likely to have idiopathic GI bleeding. Many early studies in support of the existence of Heyde syndrome used only indirect clinical criteria to demonstrate the presence of AVMs or AS, such as the presence of idiopathic GI bleeding or murmur consistent with AS. 4, 5 Some authors have questioned whether Heyde syndrome is a real entity, however, 6, 7 and recent studies that do not support the association of GI-tract AVMs have used echocardiograpic methods to define AS and visualized AVMs by GI endoscopy. [14] [15] [16] Although these studies did not show an association between these 2 entities, they were limited by their small sample sizes or lack of control groups.
POTENTIAL EXPLANATIONS FOR HEYDE SYNDROME
The mechanism of the Heyde syndrome remains unexplained, and none of the potential explanations were investigated in the present study. An earlier speculation suggested that syphilitic arteritis might cause bleeding from smaller mesenteric vessels, 12 but it has been abandoned because of the disorder's present rarity. Weaver et al 17 hypothesized that a connective tissue abnormality might cause both AVMs and AS; however, the absence of AVMs in congenital AS makes this theory less likely. 18 Another frequently cited explanation is that mucosal ischemia from the stenotic valve causes necrosis and bleeding from AVM lesions. However, because cardiac output is compromised only during the latest stages of AS, most of our patients do not fit this description. Anderson et al 19 studied the theory that the stenotic valve causes an acquired coagulopathy and showed abnormalities of the von Willebrand factor function in 3 patients with Heyde syndrome, with resolution of these abnormalities after AVR. Other potential explanations for this strong association include cholesterol embolization from the stenotic valve, 20 hypoxia-induced sympathetic nerve-mediated vasodilation, 11 and senescent processes that might affect both organs. 10 Recent reports have characterized AS as an atherosclerotic-like process. 21, 22 Future studies should look for a potential link between AVMs and atherosclerosis that may provide another connection between these 2 entities.
LIMITATIONS
In our study, despite the significantly increased prevalence of AS in patients with AVMs, the true prevalence of the Heyde syndrome may be underestimated given the strict inclusion and exclusion criteria used for patient selection. For example, patients were not included into our calculations of prevalence if one of their diagnostic procedures was performed at another hospital. Excluded patients also included those with idiopathic GI bleeding but negative results for multiple diagnostic procedures-a common occurrence in Heyde syndrome because AVM lesions are often difficult to visualize. Since our database did not include patients who underwent sigmoi- doscopy, we could not include anyone diagnosed with AVMs by the most common procedure used to visualize the colon. This certainly caused us to underestimate the prevalence of the Heyde syndrome.
Similarly, 8 patients with AVMs were excluded because of an AVR, but 7 of them had received it because of severe AS. If these patients were included in calculations of Heyde syndrome prevalence, this would increase the prevalence of AS of any severity from 31.7% (20 of 63 patients) to 37.0% (27 of 73 patients), and the prevalence of significant AS from 15.9% (10 of 63 patients) to 23.3% (17 of 73 patients). In contrast, there would have been only small increases in the prevalences of MS of any severity, from 1.6% (1 of 63 patients) to 4.1% (3 of 73), and of significant MS from 0% (0 of 63 patients) to 2.7% (2 of 73 patients).
Finally, any limitations present in a retrospective evaluation apply also to our study. As it was undertaken in a tertiary care center, the study and comparison populations may have been more selected than they would have in a general community population. Conversely, general population prevalences are likely to be overestimated at a large referral center; therefore, in a community setting the difference of AS prevalence between a general population group and patients with AVMs may be even more marked. Furthermore, our use of MS as a comparison group also introduces some bias, though the use of a general population MS control group likely compensates for this difference.
CONCLUSIONS
Our study shows that AS is significantly more prevalent in patients who have concomitant AVMs, and that the stenoses are more severe, and this may affect the management of both AVMs and AS. Current studies probably underestimate the true prevalence of the Heyde syndrome; and since there are potential changes in management of patients with a recognized Heyde syndrome, more research in this area is needed.
